Skip to main content
Abnova logo

Abnova — Investor Relations & Filings

Ticker · 4133 ISIN · TW0004133004 TW Professional, scientific and technical activities
Open in API
Filings indexed 1,483 across all filing types
Latest filing 2014-02-11 Director's Dealing
Country TW Taiwan
Listing TW 4133

About Abnova

http://www.abnova.com

Abnova Corporation is a global leader in the high-throughput production of antibodies and recombinant proteins. By integrating industrial-scale manufacturing with IT-driven management systems, the company maintains one of the world's largest catalogs of biological reagents. Its core offerings encompass gene synthesis, cytogenetics, peptide services, and protein expression. Abnova provides comprehensive solutions for life science research, including custom antibody production, scale-up, and humanization. Recent technological expansions include the RNAutomation™ mRNA service, NanoAb™ services, and nanoCAR-T mRNA solutions. The company supports academic and industrial researchers across multidisciplinary fields with integrated assay development and advanced bioreagent tools.

Recent filings

Filing Released Lang Actions
103年01月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, supervisors, general managers, and their related parties. It shows the number of shares held, changes in holdings, and other related data. There is no indication of financial statements, earnings data, or management discussion. The content is focused on insider shareholdings and transactions. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives. The document length is substantial and contains detailed insider shareholding data, not just an announcement or summary. Therefore, the appropriate classification is DIRS.
2014-02-11 Chinese
103年01月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, supervisors, and management, with specific numbers of shares held and pledged. It is a disclosure of insider shareholdings and related information. There is no indication of financial results, earnings, management discussion, or other report content. The document is focused on insider shareholding details, which corresponds to Director's Dealing filings. The document length is 3323 characters, which is relatively short but contains substantive insider shareholding data, not just an announcement or certification. Therefore, the best fitting category is Director's Dealing (DIRS).
2014-02-11 Chinese
103年1月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company (亞諾法) providing information about fund lending balances and endorsement guarantees for the current and previous month, including limits and cumulative amounts. The content is structured as tabular financial data but is very brief (610 characters) and does not contain comprehensive financial statements or detailed analysis. It appears to be a regulatory disclosure related to financial guarantees and lending, typical of a regulatory filing rather than a full report. There is no indication of it being an annual or interim report, audit report, or other specific report types. Given the short length and nature of the data, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other categories.
2014-02-10 Chinese
103年1月營業收入
Regulatory Filings Classification · 95% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 亞諾法, with data for January 2014 (民國103年01月). It includes percentage changes compared to the previous year and explanatory notes about accounting standards (IFRS) and reporting practices. The document is very short (769 characters) and does not contain detailed financial statements or comprehensive analysis. It appears to be a brief financial summary or regulatory disclosure rather than a full financial report or earnings release. There is no indication of it being an earnings release announcement or a full interim report. Given the brevity and nature of the content, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous filings that do not fit other specific categories.
2014-02-10 Chinese
102年12月營業收入
Regulatory Filings Classification · 95% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 亞諾法, with data presented in a tabular format. It includes percentage changes compared to the previous year and explanatory notes about accounting standards (IFRS) and reporting practices. The document length is short (765 characters) and it does not contain detailed financial statements or comprehensive analysis. It appears to be a regulatory disclosure of financial data rather than a full financial report. There is no indication that this is an earnings release, annual report, or interim report. Given the nature of the data and the format, this fits best as a Regulatory Filing (RNS) which is a general category for miscellaneous regulatory disclosures that do not fit other specific categories.
2014-01-10 Chinese
102年12月背書保證與資金貸與
Capital/Financing Update Classification · 90% confidence The document contains financial data related to loan balances, guarantees, and endorsements for the company and its subsidiaries, presented in a tabular format with monetary amounts. The content is focused on capital and financing details such as loan balances and guarantee limits. The document length is short (610 characters), but it contains substantive financial data rather than just an announcement or certification. There is no indication that this is a full annual or interim report, nor is it a regulatory filing or announcement. The nature of the data aligns best with a Capital/Financing Update, which covers company fundraising, financing activities, or capital structure changes.
2014-01-10 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.